PLAU, plasminogen activator, urokinase, 5328

N. diseases: 439; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0017638
Disease: Glioma
Glioma
0.100 AlteredExpression disease BEFREE The aim of current study was to provide a proof-of-concept on the mechanism of PLAU and PCDH10 gene expressions and caspases-3, -8, and -9 activities in the apoptotic pathway after treatment of malignant human glioma cell line (U87MG) with cytochalasin H. 30507090 2019
CUI: C0017638
Disease: Glioma
Glioma
0.100 AlteredExpression disease LHGDN Furthermore, key components (i.e., uPAR, uPA, and pro-MMP-2) were contributed principally by astrocytes, whereas the U251N glioma cells provided plasminogen. 12764090 2003
CUI: C0017638
Disease: Glioma
Glioma
0.100 Biomarker disease BEFREE Our results support the therapeutic potential of targeting the individual components of the uPAR-uPA system by using a single adenovirus construct for the treatment of glioma and other invasive cancers. 12955075 2003
CUI: C0017638
Disease: Glioma
Glioma
0.100 Biomarker disease BEFREE Our previous studies showed that the urokinase-type plasminogen activator receptor (uPAR) and the p16 tumor suppressor gene play a significant role in glioma invasion. 11791179 2002
CUI: C0017638
Disease: Glioma
Glioma
0.100 AlteredExpression disease BEFREE The fibrinolytic activities of conditioned medium and cell lysates from human glioma cell lines, A172, T98G, U87 and TM1 were studied by fibrin plate zymography. mRNA expression of tissue plasminogen activator (tPA), urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors (PAI-1, PAI-2) was measured by Northern blot analysis. 12241114 2002
CUI: C0017638
Disease: Glioma
Glioma
0.100 AlteredExpression disease BEFREE Our results suggested that down-regulation of uPA expression may be a feasible approach to reducing the malignancy and invasiveness of glial tumors. 11489835 2001
CUI: C0017638
Disease: Glioma
Glioma
0.100 AlteredExpression disease BEFREE Using human uPA promoter chloramphenicol acetyl transferase (CAT) constructs with mutations of the AP-1 element at -1967 or the PEA-3 cis element at -1973, the activity of the uPA promoter was decreased 4-fold to 10-fold in all three human glioma cell lines. 11115541 2001
CUI: C0017638
Disease: Glioma
Glioma
0.100 AlteredExpression disease BEFREE Expression of uPA is associated with the malignant progression, invasion and angiogenesis of gliomas, and it may play a critical role in the recurrence and prognosis of gliomas. 11776074 2000
CUI: C0017638
Disease: Glioma
Glioma
0.100 Biomarker disease BEFREE Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth. 10416596 1999
CUI: C0017638
Disease: Glioma
Glioma
0.100 Biomarker disease BEFREE Our previous studies showed that glioblastomas express increased urokinase-type plasminogen activator receptors (uPARs) in comparison to low-grade gliomas (Yamamoto et al., Cancer Res., 54, 5016-5020, 1994). 9219733 1997